Skip to main content
. 2022 Jul 7;22:122. doi: 10.1186/s12873-022-00664-y

Table 6.

Selected estimation results: main sample by comparison

Methoxyflurane Entonox® Methoxyflurane Morphine IV Methoxyflurane Paracetamol IV
Estimation Sample
 Patients 423 753 423 802 423 278
 Observations 2907 3211 1934
Variable
Ineligibilities
  Under 18 (Yes = 1) -0.064 - -0.053 - -0.075 -
  Pain mild/none (Yes = 1) -1.862** - -1.776** - -1.929** -
  GCS ineligible/missing (Yes = 1) -0.779** - -0.740** - -0.796** -
  Trauma ineligible (Yes = 1) 0.284 - 0.271 - 0.312 -
Demographics
  Sex (F = 0, M = 1) -0.402** -0.285** -0.387** -0.048 -0.409** -0.232
  Age (years) -0.003 -0.002 -0.003 -0.001 -0.003 -0.002
  Trauma #1 (Yes = 1) (reference) (reference) (reference) (reference) (reference) (reference)
  Trauma #2 (Yes = 1) -0.152 0.222 -0.143 -0.157 -0.154 -0.228
  Trauma #3 (Yes = 1) -0.362* 0.019 -0.344* -0.229 -0.359* -0.136
  Trauma #4 (Yes = 1) -0.537** -0.038 -0.502** -0.187 -0.528** -0.090
  Trauma #5 (Yes = 1) -0.048 0.062 -0.042 0.248 -0.041 -0.211
  Trauma #6 (Yes = 1) -0.650 -0.048 -0.622 -0.047 -0.658 0.181
Pathways
  Time, t -0.071** -0.108** -0.081**
  Time squared, t2 0.001** 0.001** 0.001**
  Methoxyflurane, d 0.730** - 0.422 - 0.914** -
  Methoxyflurane x Time, dt -0.135** - -0.088** - -0.128** -
  Methoxyflurane x Time2dt2 0.003** - 0.002** - 0.003** -
Medicine Use
  Nonadherence (Yes = 1) 0.707* - 0.674* - 0.724* -
  Side-effect (Yes = 1) 0.064 - 0.069 - 0.085 -
  Discontinue early (Yes = 1) 0.399 - 0.372 - 0.402 -
  Influence Entonox® (Yes = 1) -0.046 - -0.019 - -0.051 -
  Influence potency 1 (Yes = 1) 0.003 - -0.003 - 0.001 -
  Influence potency 2 (Yes = 1) -0.003 - -0.006 - -0.004 -
  Influence potency 3 (Yes = 1) 0.253 - 0.237 - 0.270 -

*p < 0.05

**p < 0.01

The trauma numbering plan is given in Table 4